secwatch.observer — SEC 8-K summary
======================================

Issuer:     TriSalus Life Sciences, Inc. (TLSI)
CIK:        0001826667
Form:       8-K
Filed at:   2025-02-03T23:59:59+00:00
Accession:  0001826667-25-000014
Event type: debt
Sentiment:  neutral
Materiality: 0.55
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TriSalus draws $10M from OrbiMed credit facility upon hitting $30M revenue milestone
--------------------------------------------------------------------------------

- $10 million drawdown under $50M credit agreement with OrbiMed triggered by achievement of $30M trailing 12-month product revenue milestone as of Jan 31, 2025.
- Total drawn under the facility now $35 million; $15 million remains available.
- Proceeds provide additional liquidity for ongoing operations and development programs.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1826667/000182666725000014/0001826667-25-000014-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1826667/000182666725000014/tlsi-20250131.htm
  HTML page:      https://secwatch.observer/filing/0001826667-25-000014

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer